Khari Griffin, a Cannabis Attorney at Clark Hill Law, joins Blunt Business to delve into the complexities of inconsistent state regulations on THC products. Key issues highlighted included concerns over high potency, youth access, and the lack of federal oversight, particularly regarding the 2018 Farm Bill and FDA inaction.
The discussion also explored the influence of lobbying and public opinion, using Texas and Georgia as case studies to illustrate varying legislative approaches and the challenges faced by the hemp industry.
We also emphasized on the need for future action from the FDA to establish clear standards for THC products, especially addressing synthetic THC.